Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America API Intermediate Market, by Type
1.4.2 North America API Intermediate Market, by End User
1.4.3 North America API Intermediate Market, by Application
1.4.4 North America API Intermediate Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Forces Analysis
Chapter 4. Strategies Deployed in API Intermediate Market
Chapter 5. North America API Intermediate Market by Type
5.1 North America Bulk Drug Intermediates Market by Country
5.2 North America Chemical Intermediates Market by Country
Chapter 6. North America API Intermediate Market by End User
6.1 North America Biotech & Pharmaceutical Companies Market by Country
6.2 North America CMO Market by Country
6.3 North America Others Market by Country
Chapter 7. North America API Intermediate Market by Application
7.1 North America Analgesics Market by Country
7.2 North America Antidiabetic Drugs Market by Country
7.3 North America Anti-Infective Drugs Market by Country
7.4 North America Cardiovascular Drugs Market by Country
7.5 North America Anticancer Drugs Market by Country
7.6 North America Others Market by Country
Chapter 8. North America API Intermediate Market by Country
8.1 US API Intermediate Market
8.1.1 US API Intermediate Market by Type
8.1.2 US API Intermediate Market by End User
8.1.3 US API Intermediate Market by Application
8.2 Canada API Intermediate Market
8.2.1 Canada API Intermediate Market by Type
8.2.2 Canada API Intermediate Market by End User
8.2.3 Canada API Intermediate Market by Application
8.3 Mexico API Intermediate Market
8.3.1 Mexico API Intermediate Market by Type
8.3.2 Mexico API Intermediate Market by End User
8.3.3 Mexico API Intermediate Market by Application
8.4 Rest of North America API Intermediate Market
8.4.1 Rest of North America API Intermediate Market by Type
8.4.2 Rest of North America API Intermediate Market by End User
8.4.3 Rest of North America API Intermediate Market by Application
Chapter 9. Company Profiles
9.1 Cation Pharma
9.1.1 Company Overview
9.1.2 SWOT Analysis
9.2 Espee Group
9.2.1 Company Overview
9.2.2 Recent strategies and developments:
9.2.2.1 Trials and Approvals:
9.3 Sandoo Pharmaceuticals and Chemicals Co., Ltd.
9.3.1 Company Overview
9.3.2 SWOT Analysis
9.4 Cipla Limited
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Regional Analysis
9.4.4 Research & Development Expense
9.4.5 SWOT Analysis
9.5 Cambrex Corporation
9.5.1 Company Overview
9.5.2 Recent strategies and developments:
9.5.2.1 Acquisition and Mergers:
9.5.3 SWOT Analysis
9.6 Vertellus
9.6.1 Company Overview
9.6.2 SWOT Analysis
9.7 Dr. Reddy’s Laboratories Ltd.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Partnerships, Collaborations, and Agreements:
9.7.6 SWOT Analysis
9.8 Evonik Industries AG (RAG-Stiftung)
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expenses
9.8.5 Recent strategies and developments:
9.8.5.1 Partnerships, Collaborations, and Agreements:
9.8.5.2 Geographical Expansions:
9.8.6 SWOT Analysis
9.9 Pfizer, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Regional & Segmental Analysis
9.9.4 Research & Development Expense
9.9.5 Recent strategies and developments:
9.9.5.1 Geographical Expansions:
9.9.6 SWOT Analysis
9.10. SHREE GANESH REMEDIES LIMITED
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 SWOT Analysis
Unique Offerings 